Submitted by Barb Corapi on Mon, 07/24/2023 - 16:33
Submitted by superuser on Mon, 07/24/2023 - 14:37
There is emerging evidence supporting the therapeutic value of ketamine therapy in depression and Psychedelic Assisted Psychotherapy Treatment (PAPTx) in several disorders. Several of these treatments are now being increasingly used in clinical practice, including Psilocybin based PAPTx for depression and MDMA based PAPTx for PTSD. However, we don’t fully understand the efficacy and safety of these therapies, especially when provided more widely outside of clinical trials. Therefore, it is essential to gather systematic information on their safety and outcomes.
Submitted by Barb Corapi on Tue, 07/18/2023 - 15:47
Pages